ADARx Pharmaceuticals Earnings
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.79-1.37 (-9.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ADARx Pharmaceuticals earnings summary
In its most recent report on Nov 12, 2026 (Sep/2026), ADRX posted EPS of $-1.74 versus the $-0.40 consensus estimate, a negative surprise of 335.0%.
Summary generated from market data by MetaCap's automated system. Methodology
ADRX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 12, 2026 | $-0.40 | $-1.74 | -335.0% | -9.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.